1. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. Issue 12 (December 2022) Authors: Keir, Holly R; Long, Merete B; Abo-Leyah, Hani; Giam, Yan Hui; Vadiveloo, Thenmalar; Pembridge, Thomas; Hull, Rebecca C; Delgado, Lilia; Band, Margaret; McLaren-Neil, Fiona; Adamson, Simon; Lahnsteiner, Eva; Gilmour, Amy; Hughes, Chloe; New, Benjamin JM; Connell, David; Dowey, Rebecca; Turton, He... Journal: Lancet Issue: Volume 10:Issue 12(2022) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗